Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Significant response to atezolizumab plus bevacizumab treatment in unresectable hepatocellular carcinoma with major portal vein tumor thrombus: a case report

Fig. 2

Abdominal computed tomography showing size reduction of the main tumor and the portal vein tumor thrombus (white arrow). The tip of the portal vein tumor thrombus has regressed from the bifurcation of the anterior and posterior branches to the left trunk, and the right portal vein is recanalized. Serum alfa-fetoprotein level decreased from 90,700 ng/mL before the treatment to 18,371 ng/mL (3 weeks later) and 89 ng/mL (2 months later). AFP, alfa-fetoprotein

Back to article page